The Denmark Blood Grouping Reagents Market has experienced a fluctuating trend over the past decade, with a notable decline from 2012 to 2017, followed by a brief resurgence in 2018, and a steady decline thereafter. The Compound Annual Growth Rate (CAGR) has shown improvement from -7.56% in 2016 to -0.44% in 2022, indicating a gradual stabilization of the market. The year-on-year variation has remained negative in the last two years, highlighting a continuous but slowing decline in market value.
Looking ahead, the Blood Grouping Reagents Market in Denmark is expected to focus on innovation and technological advancements. With the rising demand for precise and efficient blood testing methods, companies that invest in research and development to introduce novel reagents and testing solutions are likely to gain a competitive edge. Additionally, the integration of digital tools and AI for blood analysis could be a key trend driving market growth.
How does Denmark rank in Blood Grouping Reagents Market Size Value?
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
| 12 | 12 Belgium | 7,578,800 | 2023 | -0.5% | -2.57% | View data |
| 13 | 13 Croatia | 4,027,100 | 2023 | -3.49% | -1.48% | View data |
| 14 | 14 Denmark | 3,569,200 | 2023 | -2.29% | -3.12% | |
| 15 | 15 Slovenia | 3,044,600 | 2023 | -1.97% | -2.15% | View data |
| 16 | 16 Lithuania | 1,295,200 | 2023 | -1.82% | -1.82% | View data |
